Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZNF560 Inhibitors

Chemical inhibitors of ZNF560 can exert their inhibitory effects through various mechanistic pathways. Staurosporine operates as a broad-spectrum kinase inhibitor, targeting numerous kinases that are responsible for phosphorylating a range of proteins, some of which may directly or indirectly regulate the function of ZNF560. By inhibiting these kinases, Staurosporine can interfere with the phosphorylation state of these regulatory proteins, thereby obstructing the functional activity of ZNF560. Similarly, LY294002 and Wortmannin are both inhibitors of PI3K, a pivotal signaling molecule that participates in multiple cellular processes. Their inhibition of PI3K reduces the activity of downstream effectors that may be crucial for ZNF560's functional state. Rapamycin, an inhibitor of mTOR, disrupts the mTOR signaling pathway, which is integral to cellular growth and metabolism. The suppression of mTOR signaling can negatively impact the cellular environment in which ZNF560 operates, leading to its functional inhibition. Further, U0126 and PD98059 are inhibitors of MEK, a kinase within the MAPK/ERK pathway, which is known to influence the function of various proteins through phosphorylation. By inhibiting MEK, these chemicals can decrease the phosphorylation and activation of proteins that are potentially involved in regulating ZNF560, leading to its inhibition. SB203580 and SP600125 inhibit the p38 MAPK and JNK pathways, respectively, which could disrupt the signaling necessary for the optimal activity of ZNF560. Y-27632 targets the Rho/ROCK pathway, influencing cellular structure and dynamics that could be critical for ZNF560's function. Dasatinib and PP2 are Src family kinase inhibitors, and by inhibiting Src family kinases, these chemicals can reduce the phosphorylation of substrates involved in the functional regulation of ZNF560. Lastly, Gefitinib inhibits EGFR tyrosine kinase activity, which can affect downstream signaling pathways that regulate the activity of proteins interacting with ZNF560, thus leading to its functional inhibition.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent kinase inhibitor known to inhibit a wide range of kinases. Inhibits pathways involving ZNF560 by inhibiting kinases that phosphorylate proteins which may interact with or regulate ZNF560, leading to its functional inhibition.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that would inhibit PI3K pathway signaling, potentially reducing the phosphorylation of proteins that could regulate ZNF560 function, resulting in functional inhibition of ZNF560.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor which would inhibit the mTOR pathway, affecting downstream signaling that may be necessary for ZNF560 function, thus functionally inhibiting ZNF560.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

A MEK inhibitor which would inhibit the MAPK/ERK pathway, potentially decreasing the phosphorylation of transcription factors or other proteins that could be important for the functional regulation of ZNF560.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor which would disrupt p38 MAPK pathway signaling, potentially leading to the functional inhibition of proteins that interact with or regulate ZNF560.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor, which would inhibit JNK signaling, potentially disrupting protein interactions and regulatory processes that are critical for ZNF560 function, thus functionally inhibiting ZNF560.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A PI3K inhibitor that would inhibit PI3K/Akt signaling, leading to diminished regulation or modification of proteins that control ZNF560 activity, resulting in functional inhibition of ZNF560.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

A MEK inhibitor which would prevent the activation of the MAPK/ERK pathway, potentially affecting the function of ZNF560 by reducing the phosphorylation of associated proteins that regulate its activity.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor which would inhibit Rho/ROCK signaling, potentially altering the cytoskeletal dynamics and cellular contexts that may be important for the functional activity of ZNF560.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

A Src family kinase inhibitor which could inhibit Src kinase activity, potentially reducing phosphorylation of substrates that regulate or are involved in the functional activity of ZNF560.